DOL Announces New LM-10 Guidance and Extended Filing Deadline
Client Alert | 1 min read | 03.09.06
On March 7, 2006, the U.S. Department of Labor ("DOL") issued new guidance on employers' LM-10 reporting requirements in the form of additional Frequently Asked Questions (FAQ) added to the DOL's Advisory and FAQ issued in November 2005.
The DOL's November 2005 Advisory indicated a much more aggressive enforcement posture with respect to LM-10 reporting, but also created a grace period for reporting -- employers who file compliant LM-10 forms within 90 days of the company's 2005 fiscal year will not be penalized for their failure to submit reports for any prior years. The revised FAQ announces that employers whose fiscal year ended December 31, 2005 will now have until May 15, 2006 to file their fiscal year 1005 LM-10s
The revised Advisory and FAQs clarify who must file annual LM-10 reports, provide additional examples of reportable expenditures, and explain how an employer who has no reportable expenditures for the 2005 fiscal year can still take advantage of the grace period. Unionized employers should carefully review the revised FAQ, as well as the underlying statutes and case law in this very complicated area of the law, to determine their reporting requirements and ensure that appropriate processes are in place to track reportable expenditures.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief



